# Airway Stents Market > Airway Stents Market Research Report: Size, Share, Trend Analysis By Stent Material (Metallic Stents, Silicone Stents, Polyurethane Stents), By Types (Self-expanding Stents, Balloon-expandable Stents, Covered Stents, Uncovered Stents), By Applications (Tracheal Stents, Bronchial Stents, Esophageal Stents, Other Airway Stents), By Length ( 5 cm, 5-10 cm, 10-15 cm, > 15 cm), By Diameter ( 10 mm, 10-15 mm, 15-20 mm, > 20 mm) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.15% - **2024:** $ 3.91 Billion - **2025:** $ 4.15 Billion - **2035:** $ 7.53 Billion - **Key Players:** Boston Scientific (US), Medtronic(US), Cook Medical (US), Bard Peripheral Vascular (US), Conmed Corporation (US), Teleflex (US), Halyard Health (US), Olympus Corporation (JP), Stryker Corporation (US) **Report ID:** MRFR/HC/38660-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/airway-stents-market-40694 --- ## Market Summary ## **Airway Stents Market Overview** As per MRFR analysis, the Airway Stents Market Size was estimated at 3.47 (USD Billion) in 2022. The Airway Stents Market Industry is expected to grow from 3.68(USD Billion) in 2023 to 6.3 (USD Billion) by 2032. The Airway Stents Market CAGR (growth rate) is expected to be around 6.15% during the forecast period (2024 - 2032). ### **Key Airway Stents Market Trends Highlighted** Airway stents market is primarily driven by the increasing incidence of respiratory diseases such as chronic obstructive pulmonary disease as well as asthma. With the bio-absorbable self-expanding stents, technology adoption helped improve patient outcomes and the market. Change in the patients’ perceptions regarding the airway stents along with growing requirement for low invasive surgeries adds to the growth. Increased healthcare expenditure and rising prevalence of respiratory diseases provide doorways for airway stent implants manufacturers in emerging economies. Technological enhancement in stents designs and accrued materials looks promising in improving the outcome of a patient and the applications. The possibilities of more extended application in the market as well as enhancing the patients' care are in the development of the drug eluting stents and biodegradable stents. Prompting trends in the airway stents market concern self-expanding stents with increased rates of adoption because they provide better conformability to the airway structure and lower complications risks. Self-expanding stents, due to less complex airway structure are booming the development of balloon expandable stents that possess better flexibility to make developing mature stents easier. Furthermore, drug coated stents have the potential of improving the outcomes of treatment and reducing the rates of restenosis which is caused by adverse drug reactions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Airway Stents Market Drivers** ### Rising Prevalence of Respiratory Diseases The increasing incidence of respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer, is a major driver of the Airway Stents Market. These conditions can cause airway narrowing and obstruction, making it difficult for patients to breathe. Airway stents can help to keep the airways open, improving airflow and reducing symptoms. According to the World Health Organization (WHO), approximately 262 million people worldwide suffer from asthma, while COPD affects around 384 million individuals.The rising prevalence of these diseases is expected to continue to drive demand for airway stents in the coming years. ### Technological Advancements The Airway Stents Market Industry has witnessed significant advancements in stent design and materials, leading to improved performance and patient outcomes. The development of self-expanding stents, which can adapt to the shape of the airway, has enhanced stent placement accuracy and reduced the risk of complications. Additionally, the introduction of bioresorbable stents, which gradually dissolve over time, eliminates the need for a second procedure to remove the stent.These technological advancements are expected to further drive the adoption of airway stents in the coming years. ### Growing Geriatric Population The aging population is another key factor driving the growth of the Airway Stents Market Industry. As people age, they are more likely to develop respiratory conditions that may require airway stents. The increasing number of elderly patients is expected to contribute to the demand for airway stents in the coming years. ## **Airway Stents Market Segment Insights** ### **Airway Stents Market Stent Material Insights ** The Airway Stents Market is segmented based on stent material into Metallic Stents, Silicone Stents, and Polyurethane Stents. Metallic Stents dominated the Airway Stents Market in 2023, accounting for over 55% of the market revenue. These stents are made of materials such as Nitinol, stainless steel, and cobalt-chromium alloys, offering excellent radial force and flexibility for effective airway patency. Their durability and ability to withstand compression make them suitable for long-term airway management. Silicone Stents held a significant share of around 30% in the Airway Stents Market in 2023.These stents are made of medical-grade silicone, known for its biocompatibility, flexibility, and ability to conform to complex airway anatomies. Silicone stents are commonly used for short-term airway management, such as in cases of tracheomalacia or tracheal stenosis, due to their low risk of tissue damage and encrustation. Polyurethane Stents accounted for a smaller share in the Airway Stents Market in 2023, approximately 15%. Made of polyurethane materials, these stents offer a balance of flexibility and strength. They are often used in situations where there is a need for both rigidity and flexibility, such as in the management of complex airway obstructions or tracheoesophageal fistulas.The Airway Stents Market is expected to witness steady growth in the coming years, driven by factors such as the rising prevalence of respiratory diseases, increasing demand for minimally invasive procedures, and technological advancements in stent design. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Airway Stents Market Type Insights ** The Airway Stents Market is segmented by Type into Self-expanding Stents, Balloon-expandable Stents, Covered Stents, and Uncovered Stents. Among these, the Self-expanding Stents segment is expected to hold the largest market share in 2023, owing to their advantages such as ease of insertion and conformability to the airway. The Balloon-expandable Stents segment is projected to witness the fastest growth during the forecast period, due to the increasing adoption of minimally invasive procedures. Covered Stents are expected to gain traction in the market due to their ability to prevent tissue ingrowth and migration.Uncovered Stents are commonly used for short-term airway stenting and are expected to maintain a steady market share. The Airway Stents Market is expected to reach a valuation of USD 6.3 billion by 2032, exhibiting a CAGR of 6.15% during the forecast period. ### **Airway Stents Market Application Insights ** The Airway Stents Market is segmented based on application into Tracheal Stents, Bronchial Stents, Esophageal Stents, and Other Airway Stents. In 2023, the Tracheal Stents segment held the largest market share, accounting for around 42.1% of the Airway Stents Market revenue. Bronchial Stents segment is projected to grow at the highest CAGR of 6.7% during the forecast period 2023-2032. The growth of this segment can be attributed to the increasing prevalence of chronic respiratory diseases, such as asthma and COPD, which require the use of bronchial stents to maintain airway patency.Esophageal Stents segment is expected to witness a significant growth rate due to the rising incidence of esophageal cancer and gastroesophageal reflux disease (GERD). Other Airway Stents segment includes stents used in the treatment of laryngeal stenosis, tracheobronchomalacia, and other airway disorders. This segment is also expected to grow at a steady pace during the forecast period. ### **Airway Stents Market Length Insights ** The Length segment of the Airway Stents Market is segmented into ' 5 cm', '5-10 cm', '10-15 cm', and '> 15 cm'. The ' 5 cm' segment is expected to hold the largest share of the market in 2023, accounting for around 40% of the Airway Stents Market revenue. This is due to the increasing prevalence of short-segment airway stenosis, which is often treated with stents less than 5 cm in length. The '5-10 cm' segment is expected to be the fastest-growing segment, with a CAGR of 6.5% from 2024 to 2032. This growth is attributed to the rising incidence of moderate-length airway stenosis, which is typically treated with stents in the 5-10 cm range.The '10-15 cm' and '> 15 cm' segments are expected to account for a smaller share of the market, but they are still expected to experience steady growth over the forecast period. ### **Airway Stents Market Diameter Insights ** The Airway Stents Market is segmented by diameter, which includes ' 10 mm', '10-15 mm', '15-20 mm', and '> 20 mm'. Among these segments, the '10-15 mm' diameter segment is expected to account for the largest share of the market in 2023, owing to the increasing prevalence of tracheobronchial diseases and the growing demand for minimally invasive procedures. The ' 10 mm' diameter segment is also expected to witness significant growth over the forecast period, due to the rising incidence of pediatric airway disorders and the development of new stents specifically designed for smaller airways. ### **Airway Stents Market Regional Insights ** The regional segmentation of the Airway Stents Market offers valuable insights into the market's dynamics across different geographies. North America dominates the market with a significant share, driven by factors such as the high prevalence of respiratory diseases, advanced healthcare infrastructure, and favorable reimbursement policies, with values of 1.619 billion USD in 2023 and 2.706 billion USD in 2032. Europe holds the second position, owing to the presence of a large patient population, well-established healthcare systems, and increasing awareness about airway stents, with values of 0.886 billion USD in 2023 and 1.521 billion USD in 2032. The APAC region is anticipated to witness substantial growth in the coming years, attributed to the rising incidence of lung diseases, improving healthcare access, and government initiatives to enhance healthcare infrastructure, with values of 0.813 billion USD in 2023 and 1.433 billion USD in 2032.South America and MEA display moderate growth potential, with opportunities emerging due to increasing medical tourism and investments in healthcare development, with values of 0.161 billion USD in 2023 and 0.28 billion USD in 2032 for South America, and 0.201 billion USD in 2023 and 0.36 billion USD in 2032 for the Middle East and Africa. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Airway Stents Market Key Players and Competitive Insights** Major players in the Airway Stents Market are focused on developing innovative products to meet the evolving needs of patients. They are also investing in research and development to improve the efficacy and safety of their products. The Airway Stents Market industry is characterized by a high level of competition, with leading Airway Stents Market players adopting various strategies to gain market share. These strategies include product innovation, strategic partnerships, and mergers and acquisitions. Airway Stents Market development is driven by the increasing prevalence of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The growing demand for minimally invasive procedures is also contributing to the growth of the market. Airway Stents Market Competitive Landscape is expected to remain competitive in the coming years, with leading players continuing to invest in product development and marketing strategies to maintain their market position.Medtronic plc is a leading player in the Airway Stents Market. The company offers a wide range of airway stents, including the Airway Stent System and the Ultraflex Stent. Medtronic plc is committed to providing innovative solutions for the treatment of respiratory diseases. The company has a strong global presence and a well-established distribution network. It also has a strong track record of successful product development and commercialization.Boston Scientific Corporation is a leading competitor in the Airway Stents Market. The company offers a range of airway stents, including the FlexStent and the ExpressLD Stent. Boston Scientific Corporation is focused on developing innovative products that meet the needs of patients and healthcare providers. The company has a strong global presence and a well-established distribution network. It also has a strong track record of successful product development and commercialization. ### **Key Companies in the Airway Stents Market Include** ## Airway Stents Market Industry Developments - **Q2 2024: Boston Scientific Announces U.S. FDA Approval of the AEROmini® Tracheobronchial Stent** Boston Scientific received FDA approval for its AEROmini® Tracheobronchial Stent, expanding its airway management portfolio with a device designed for the treatment of tracheobronchial strictures. - **Q2 2024: Merit Medical Systems Launches New Endotek® Silicone Airway Stent in Europe** Merit Medical Systems announced the commercial launch of its new Endotek® Silicone Airway Stent in select European markets, aiming to address airway obstructions with improved patient comfort. - **Q3 2024: Micro-Tech Endoscopy Receives CE Mark for Next-Generation Bioresorbable Airway Stent** Micro-Tech Endoscopy was granted CE Mark approval for its next-generation bioresorbable airway stent, enabling commercialization in the European Union for patients with benign airway strictures. - **Q3 2024: Olympus Announces Strategic Partnership with Broncus Medical to Advance Airway Stent Technologies** Olympus Corporation entered a strategic partnership with Broncus Medical to co-develop and commercialize advanced airway stent solutions, focusing on minimally invasive therapies for airway management. - **Q4 2024: Boston Scientific Expands Airway Stent Manufacturing Facility in Ireland** Boston Scientific announced the expansion of its airway stent manufacturing facility in Galway, Ireland, to increase production capacity and support global demand for its airway management products. - **Q1 2025: Merit Medical Systems Receives FDA Clearance for Endotek® Hybrid Airway Stent** Merit Medical Systems received FDA clearance for its Endotek® Hybrid Airway Stent, a device designed to combine the benefits of metal and silicone stents for complex airway strictures. - **Q1 2025: Micro-Tech Endoscopy Launches Bioresorbable Airway Stent in Asia-Pacific Markets** Micro-Tech Endoscopy announced the commercial launch of its bioresorbable airway stent in select Asia-Pacific countries following regulatory approvals, targeting benign airway stenosis. - **Q2 2025: Boston Scientific Acquires Airway Innovations, Expanding Interventional Pulmonology Portfolio** Boston Scientific completed the acquisition of Airway Innovations, a company specializing in novel airway stent technologies, to strengthen its interventional pulmonology offerings. - **Q2 2025: Olympus Receives FDA 510(k) Clearance for New Self-Expanding Metallic Airway Stent** Olympus Corporation received FDA 510(k) clearance for its new self-expanding metallic airway stent, designed for the treatment of malignant central airway obstructions. - **Q2 2025: Micro-Tech Endoscopy Announces Opening of New Airway Stent Manufacturing Facility in Germany** Micro-Tech Endoscopy opened a new manufacturing facility in Germany dedicated to the production of airway stents, aiming to meet growing demand in the European market. ## Airway Stents Market Segmentation Insights ### **Airway Stents Market Stent Material Outlook** ### **Airway Stents Market Type Outlook** ### **Airway Stents Market Application Outlook** ### **Airway Stents Market Length Outlook** ### **Airway Stents Market Diameter Outlook** ### **Airway Stents Market Regional Outlook** ## Market Drivers ### Growing Awareness and Early Diagnosis There is a growing awareness of respiratory diseases and the importance of early diagnosis, which is positively impacting the Airway Stents Market. Increased public health campaigns and educational initiatives are leading to earlier detection of conditions that may require airway stenting. This heightened awareness is likely to result in more patients seeking medical attention sooner, thereby increasing the demand for airway stents. Furthermore, advancements in diagnostic technologies are enabling healthcare providers to identify airway obstructions more effectively. As a result, the Airway Stents Market is expected to benefit from this trend, with an anticipated rise in the number of procedures performed. ### Rising Incidence of Respiratory Diseases The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, is a primary driver of the Airway Stents Market. According to recent data, respiratory diseases account for a significant portion of global morbidity and mortality. This trend is likely to escalate the demand for airway stents, as they are essential for managing airway obstructions caused by these conditions. The Airway Stents Market is projected to witness substantial growth, with estimates suggesting a compound annual growth rate (CAGR) of around 7% over the next few years. As healthcare systems adapt to the rising burden of respiratory illnesses, the need for effective interventions, including airway stenting, becomes increasingly critical. ### Technological Innovations in Stent Design Technological advancements in stent design and materials are transforming the Airway Stents Market. Innovations such as drug-eluting stents and biodegradable materials are enhancing the efficacy and safety of airway stenting procedures. These advancements not only improve patient outcomes but also reduce the risk of complications associated with traditional stents. The introduction of advanced imaging techniques and minimally invasive procedures further supports the growth of the Airway Stents Market. As healthcare providers increasingly adopt these innovative solutions, the market is expected to expand, with a projected increase in stent utilization rates. This trend indicates a shift towards more effective and patient-friendly treatment options. ### Regulatory Support and Reimbursement Policies Supportive regulatory frameworks and favorable reimbursement policies are crucial drivers of the Airway Stents Market. Governments and health organizations are increasingly recognizing the importance of airway stenting as a viable treatment option for patients with respiratory conditions. This recognition is leading to improved reimbursement rates for airway stenting procedures, making them more accessible to patients. Additionally, regulatory bodies are streamlining the approval processes for new stent technologies, encouraging innovation within the market. As reimbursement policies continue to evolve in favor of airway stenting, the Airway Stents Market is likely to experience significant growth, driven by increased patient access to these essential medical devices. ### Aging Population and Increased Healthcare Expenditure The aging population is a significant factor influencing the Airway Stents Market. As individuals age, the likelihood of developing respiratory conditions increases, leading to a higher demand for airway stenting procedures. Additionally, rising healthcare expenditure in many regions is facilitating access to advanced medical technologies, including airway stents. This demographic shift is expected to drive market growth, with projections indicating that the elderly population will account for a larger share of healthcare spending in the coming years. Consequently, the Airway Stents Market is poised for expansion as healthcare systems adapt to meet the needs of an aging population. ## Future Outlook The Airway Stents Market is projected to grow at a 6.15% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of respiratory diseases, and rising healthcare expenditure. **New opportunities:** - Development of biodegradable airway stents for enhanced patient outcomes. Expansion into emerging markets with tailored product offerings. Investment in telemedicine solutions for remote stent monitoring. By 2035, the Airway Stents Market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Stent Material: Metallic Stents (Largest) vs. Silicone Stents (Fastest-Growing) In the Airway Stents Market, the stent material segment is divided into metallic, silicone, and polyurethane stents, with metallic stents currently holding the largest market share. This is primarily due to their durability, strength, and effective performance in airway management. Silicone stents, on the other hand, while smaller in share, are emerging rapidly as a preferred option due to their biocompatibility and flexibility, facilitating a significant shift in market dynamics. Growth trends within the stent material segment reflect a shift towards patient comfort and enhanced clinical outcomes. Silicone stents are anticipated to grow the fastest as they offer better tissue integration and reduced complications. The rise in pulmonary diseases and the demand for minimally invasive procedures are major drivers propelling the growth of both silicone and metallic stents, shaping the future of airway management solutions. Metallic Stents (Dominant) vs. Silicone Stents (Emerging) Metallic stents are considered the dominant force in the airway stents market, known for their structural integrity and long-term efficacy in maintaining airway patency. Their use in various clinical settings, such as in conditions like tracheobronchial obstruction, has solidified their position due to reliable performance and ease of deployment. Conversely, silicone stents are emerging as a valuable alternative, particularly favored for their flexibility and minimized irritation to surrounding tissues. This segment is gaining traction as healthcare providers seek options that reduce post-procedure complications and enhance patient experiences. The attractive characteristics of both stent materials signify a dynamic interplay in the market, with each catering to specific clinical needs. ### By Type: Self-expanding Stents (Largest) vs. Balloon-expandable Stents (Fastest-Growing) Within the Airway Stents Market, self-expanding stents hold the largest market share due to their significant advantages in terms of ease of placement and effectiveness in various clinical scenarios. Conversely, balloon-expandable stents are gaining traction as they are recognized for their precision in treatment and quick deployment trends in the airway stents market are characterized by the rising prevalence of respiratory diseases, which drives the demand for airway stenting procedures. Additionally, technological advancements and increased investments in healthcare further enhance the adoption of innovative stenting solutions, indicating strong growth potential for both self-expanding and balloon-expandable stents in the coming years. Self-expanding Stents (Dominant) vs. Covered Stents (Emerging) Self-expanding stents are the dominant players in the airway stents market, primarily due to their favorable characteristics such as flexibility, adaptability, and the ability to maintain patency in complex airway anatomies. They are commonly utilized in patients with significant airway obstruction and offer significant benefits in preventing re-obstruction. On the other hand, covered stents are an emerging segment that provides additional functionality by preventing tissue ingrowth and migration, which can be crucial in certain patient populations. While covered stents are gaining attention for their unique advantages, self-expanding stents maintain a stronghold as the preferred choice for clinicians in many applications. ### By Application: Bronchial Stents (Largest) vs. Tracheal Stents (Fastest-Growing) In the Airway Stents Market, bronchial stents take the lead as the largest segment, primarily driven by the increasing prevalence of chronic obstructive pulmonary disease (COPD) and lung cancer. These stents are essential for maintaining airway patency in patients with severe respiratory conditions, marking their dominance in market share. Conversely, tracheal stents are witnessing significant traction, attributed to rising surgical interventions and advancements in stent technologies that cater to complex airway management. Bronchial Stents (Dominant) vs. Tracheal Stents (Emerging) Bronchial stents represent the dominant force in the Airway Stents Market, offering solutions that enhance airflow and alleviate respiratory distress in patients with airway obstructions. Their design accommodates varying degrees of stenosis and provides significant clinical benefits. In contrast, tracheal stents, while currently positioned as an emerging segment, are gaining momentum due to innovations in biocompatible materials and customization options. These advancements facilitate better patient outcomes and cater to a wider range of tracheal anomalies, thus establishing their relevance in the evolving landscape of airway stent applications. ### By Length: 5-10 cm (Largest) vs. 10-15 cm (Fastest-Growing) In the Airway Stents Market, the length segment displays a diverse distribution among its categories. The 5-10 cm range is the largest segment, capturing a significant share of the market due to its versatility and widespread application in various medical procedures. Following closely is the 10-15 cm range, which, while smaller in market share, exhibits noteworthy growth potential thanks to increasing demand in complex airway surgeries and patient-specific needs. Current growth trends in the airway stents market indicate that the 10-15 cm segment is rapidly emerging as a focal point for innovation and development. Factors such as rising incidences of chronic obstructive pulmonary disease (COPD) and asthma are driving surgeons to prefer longer stents that offer better compatibility with various airway anatomies. Consequently, there is a growing emphasis on research and development to create specialized stents that cater to this demand, solidifying their position in the market and driving growth even further. 5 cm (Dominant) vs. > 15 cm (Emerging) The 5 cm segment in the Airway Stents Market is characterized as the dominant player, primarily due to its established use in treating a range of airway obstructions and its ample availability. This length is particularly favored for its balance between flexibility and strength, allowing for efficient airflow management in patients with less severe obstructions. However, the > 15 cm segment is gaining attention as an emerging solution driven by the need for stents that can accommodate complex cases and larger airway dimensions. Despite being smaller in market share, the > 15 cm category is receiving increased interest from manufacturers focusing on innovation. The development of longer stents is being fueled by advancements in materials and technology, making them a vital area for growth in the market. ### By Diameter: 15-20 mm (Largest) vs. > 20 mm (Fastest-Growing) In the Airway Stents Market, the diameter segment is characterized by a diverse range of sizes including 10 mm, 10-15 mm, 15-20 mm, and > 20 mm. The 15-20 mm diameter group holds the largest share. This dominance is attributed to the high prevalence of conditions requiring stent implantation in this size range. The other segments, while present in the market, have smaller shares, with the 10 mm size being less favored due to constraints in airway management effectiveness. Diameter: 15-20 mm (Dominant) vs. > 20 mm (Emerging) The 15-20 mm segment of the airway stents market is dominant due to its solid effectiveness in managing various respiratory conditions such as tumors, strictures, and chronic obstructive pulmonary disease (COPD). Its design effectively balances airflow and minimizes complications. In contrast, the > 20 mm segment is emerging rapidly, driven by an increasing patient population that presents with larger airway obstructions. The innovation in materials and technology for larger stents is facilitating their acceptance in routine clinical practice, positioning them as critical options for complex cases. ## Regional Market Share Analysis The regional segmentation of the Airway Stents Market offers valuable insights into the market's dynamics across different geographies. North America dominates the market with a significant share, driven by factors such as the high prevalence of respiratory diseases, advanced healthcare infrastructure, and favorable reimbursement policies, with values of 1.619 billion USD in 2023 and 2.706 billion USD in 2032. Europe holds the second position, owing to the presence of a large patient population, well-established healthcare systems, and increasing awareness about airway stents, with values of 0.886 billion USD in 2023 and 1.521 billion USD in 2032. The APAC region is anticipated to witness substantial growth in the coming years, attributed to the rising incidence of lung diseases, improving healthcare access, and government initiatives to enhance healthcare infrastructure, with values of 0.813 billion USD in 2023 and 1.433 billion USD in 2032.South America and MEA display moderate growth potential, with opportunities emerging due to increasing medical tourism and investments in healthcare development, with values of 0.161 billion USD in 2023 and 0.28 billion USD in 2032 for South America, and 0.201 billion USD in 2023 and 0.36 billion USD in 2032 for the Middle East and Africa. ## Competitive Benchmarking Major players in the Airway Stents Market are focused on developing innovative products to meet the evolving needs of patients. They are also investing in research and development to improve the efficacy and safety of their products. The Airway Stents Market industry is characterized by a high level of competition, with leading Airway Stents Market players adopting various strategies to gain market share. These strategies include product innovation, strategic partnerships, and mergers and acquisitions. Airway Stents Market development is driven by the increasing prevalence of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD).The growing demand for minimally invasive procedures is also contributing to the growth of the market. Airway Stents Market Competitive Landscape is expected to remain competitive in the coming years, with leading players continuing to invest in product development and marketing strategies to maintain their market position.Medtronic plc is a leading player in the Airway Stents Market. The company offers a wide range of airway stents, including the Airway Stent System and the Ultraflex Stent. Medtronic plc is committed to providing innovative solutions for the treatment of respiratory diseases.The company has a strong global presence and a well-established distribution network. It also has a strong track record of successful product development and commercialization.Boston Scientific Corporation is a leading competitor in the Airway Stents Market. The company offers a range of airway stents, including the FlexStent and the ExpressLD Stent. Boston Scientific Corporation is focused on developing innovative products that meet the needs of patients and healthcare providers. The company has a strong global presence and a well-established distribution network. It also has a strong track record of successful product development and commercialization. ## Recent News & Developments - **Q2 2024: Boston Scientific Announces U.S. FDA Approval of the AEROmini® Tracheobronchial Stent** Boston Scientific received FDA approval for its AEROmini® Tracheobronchial Stent, expanding its airway management portfolio with a device designed for the treatment of tracheobronchial strictures. - **Q2 2024: Merit Medical Systems Launches New Endotek® Silicone Airway Stent in Europe** Merit Medical Systems announced the commercial launch of its new Endotek® Silicone Airway Stent in select European markets, aiming to address airway obstructions with improved patient comfort. - **Q3 2024: Micro-Tech Endoscopy Receives CE Mark for Next-Generation Bioresorbable Airway Stent** Micro-Tech Endoscopy was granted CE Mark approval for its next-generation bioresorbable airway stent, enabling commercialization in the European Union for patients with benign airway strictures. - **Q3 2024: Olympus Announces Strategic Partnership with Broncus Medical to Advance Airway Stent Technologies** Olympus Corporation entered a strategic partnership with Broncus Medical to co-develop and commercialize advanced airway stent solutions, focusing on minimally invasive therapies for airway management. - **Q4 2024: Boston Scientific Expands Airway Stent Manufacturing Facility in Ireland** Boston Scientific announced the expansion of its airway stent manufacturing facility in Galway, Ireland, to increase production capacity and support global demand for its airway management products. - **Q1 2025: Merit Medical Systems Receives FDA Clearance for Endotek® Hybrid Airway Stent** Merit Medical Systems received FDA clearance for its Endotek® Hybrid Airway Stent, a device designed to combine the benefits of metal and silicone stents for complex airway strictures. - **Q1 2025: Micro-Tech Endoscopy Launches Bioresorbable Airway Stent in Asia-Pacific Markets** Micro-Tech Endoscopy announced the commercial launch of its bioresorbable airway stent in select Asia-Pacific countries following regulatory approvals, targeting benign airway stenosis. - **Q2 2025: Boston Scientific Acquires Airway Innovations, Expanding Interventional Pulmonology Portfolio** Boston Scientific completed the acquisition of Airway Innovations, a company specializing in novel airway stent technologies, to strengthen its interventional pulmonology offerings. - **Q2 2025: Olympus Receives FDA 510(k) Clearance for New Self-Expanding Metallic Airway Stent** Olympus Corporation received FDA 510(k) clearance for its new self-expanding metallic airway stent, designed for the treatment of malignant central airway obstructions. - **Q2 2025: Micro-Tech Endoscopy Announces Opening of New Airway Stent Manufacturing Facility in Germany** Micro-Tech Endoscopy opened a new manufacturing facility in Germany dedicated to the production of airway stents, aiming to meet growing demand in the European market. ## Report Scope | MARKET SIZE 2024 | 3.906(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 4.147(USD Billion) | | MARKET SIZE 2035 | 7.532(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.15% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Cook Medical (US), Bard Peripheral Vascular (US), Conmed Corporation (US), Teleflex (US), Halyard Health (US), Olympus Corporation (JP), Stryker Corporation (US) | | Segments Covered | Stent Material, Types, Applications, Length, Diameter, Regional | | Key Market Opportunities | Advancements in biocompatible materials enhance patient outcomes in the Airway Stents Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the airway stents market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Airway Stents Market as of 2024?** A: The Airway Stents Market was valued at 3.906 USD Billion in 2024. **Q: What is the projected market valuation for the Airway Stents Market in 2035?** A: The market is projected to reach 7.532 USD Billion by 2035. **Q: What is the expected CAGR for the Airway Stents Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Airway Stents Market during 2025 - 2035 is 6.15%. **Q: Which companies are considered key players in the Airway Stents Market?** A: Key players in the market include Boston Scientific, Medtronic, Cook Medical, and Teleflex. **Q: What are the main segments of the Airway Stents Market based on stent material?** A: The main segments based on stent material include Metallic Stents, Silicone Stents, and Polyurethane Stents. **Q: How do the valuations of self-expanding and balloon-expandable stents compare?** A: Self-expanding Stents were valued at 1.173 USD Billion, while Balloon-expandable Stents were valued at 0.781 USD Billion in 2024. **Q: What is the valuation range for bronchial stents from 2024 to 2035?** A: Bronchial Stents were valued at 1.17 USD Billion in 2024 and are projected to reach 2.2 USD Billion by 2035. **Q: What is the market performance of stents based on their length?** A: Stents measuring 5-10 cm were valued at 1.172 USD Billion in 2024, with projections of 2.234 USD Billion by 2035. **Q: What is the valuation of esophageal stents in 2024?** A: Esophageal Stents were valued at 0.78 USD Billion in 2024. **Q: How does the diameter of stents affect their market valuation?** A: Stents with a diameter of 10-15 mm were valued at 1.172 USD Billion in 2024, indicating a strong market presence. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/airway-stents-market-40694*